What anticoagulants are recommended for reducing the risk of recurrent stroke in patients with nonvalvular AF and stroke or TIA?
In patients with nonvalvular AF and stroke or TIA, oral anticoagulation (eg, apixaban, dabi- gatran, edoxaban, rivaroxaban, or warfarin) is recommended to reduce the risk of recurrent stroke. In patients with AF and stroke or TIA, without moderate to severe mitral stenosis or a mechanical heart valve, who are unable to maintain a therapeutic INR level with warfarin, use of dabigatran, rivaroxaban, apixaban, or edoxaban is recommended to reduce the risk of recurrent stroke.